Human medicines European public assessment report (EPAR): Arexvy, Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E, Date of authorisation: 06/06/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Arexvy, Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E, Date of authorisation: 06/06/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Arexvy, Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E, Date of authorisation: 06/06/2023, Revision: 5, Status: Authorised
